FindTrial
Sign In

Comparison of autologous platelet rich fibrin and transplantation of autologous noncultured epidermal cell suspension in the treatment of chronic non healing ulcer

Comparison of autologous platelet rich fibrin and transplantation of autologous noncultured epidermal cell suspension in the treatment of chronic non healing ulcer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017788
Enrollment
50
Registered
2019-02-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L89- Pressure ulcer

Interventions

Intervention1: Autologous platelet rich fibrin group: Follow up will be done at every 2 weeks for first 2 months then monthly till ulcer heals or 5 months Control Intervention1: Transplantation of aut

Sponsors

Department of Dermatology and Venereology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: chronic non healing ulcer of more than 6 weeks due to leprosy and diabetes and venous ulcer

Exclusion criteria

Exclusion criteria: age below 18 years size more than 5x5 cm pregnant and lactating woman underlying osteomyelitis patients in sepsis malignancy bleeding disorder platelet below 1 lakh patients on anticoagulant medication uncontrolled diabetes mellitus malignant ulcer

Design outcomes

Primary

MeasureTime frame
To evaluate the reduction in ulcer size over 5 monthsTimepoint: Follow up at every 2 weeks for first 2 months then monthly till 5 months—

Secondary

MeasureTime frame
To evaluate time to ulcer healing and improvement in discomfort and quality of lifeTimepoint: Follow up at every 2 weeks for first 2 months then monthly till 5 months—

Countries

India

Contacts

Public ContactSri Rupa

Institute of Medical Sciences BHU

drsatyendraderma@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026